Lisa Holmes

Lisa Holmes is a seasoned professional in market access and reimbursement with extensive experience in the pharmaceutical industry. Currently serving as Senior Director at Incyte since May 2020, Lisa leads a Field Access Management team to facilitate the launch of tafasitamab and future drugs, focusing on optimizing access for physician-administered treatments. Prior to Incyte, Lisa held various senior director roles at Teva Pharmaceuticals from May 2008 to May 2020, where responsibilities included overseeing reimbursement strategies and leading complex market access initiatives for physician-administered products. Lisa's career began at AstraZeneca, where achievements included enhancing access and market share for oncology products and leading strategic plans for respiratory franchises. Early career experience includes roles at Wyeth Pharmaceuticals as a Medical Sales Representative and Regional Sales Trainer. Lisa holds a BBA in Marketing from the Fox School of Business at Temple University.